
Today we’re announcing our collaboration with @Roche to use Chai’s AI models for drug discovery. More ↓
✓
Today we’re announcing our collaboration with @Roche to use Chai’s AI models for drug discovery. More ↓


Full list: disruptors60.ai/ Thanks @GreenfieldVC for including Chai.

Chai Discovery has been named an AI Pioneer in the 2026 #Disruptors60, unveiled at @TechCrunch Disrupt. Each year, 60 emerging AI startups are recognized as Disruptors, alongside 15 Pioneers already leading at scale. We're in great company alongside @AppliedInt, @FireworksAI_HQ, @OpenEvidence and more. Full list ↓


Thanks @AndrewE_Dunn and @endpts for covering endpoints.news/chai-discover…


AI in drug discovery isn't just a speed play. It unlocks new therapeutic strategies once out of reach. At the CDD & AI for Biologics Summit today, Chai’s Ryan Peckner will share how Chai’s latest models can design precise, novel antibodies for hard targets: cdd-ai-biologics.com/speaker…


Announcing Chai × @BMSnews. BMS has spent decades developing medicines for patients with serious diseases. Now it will leverage Chai's AI models to support future discoveries, unlocking challenging targets and compressing the timeline from drug concept to candidate.

Tune in to @latentspacepod to hear @Mattmcpartlon1 and @realdealpatil talk about the transformational moment bio AI is going through, and why you don't need a background in biology to make an impact in the space.

We started Chai with a mission to enable the next generation of breakthrough medicines. Hear our co-founders @joshim5 and @Mattmcpartlon1 talk to @gradypb on @sequoia's Training Data to talk about the future of AI drug design. Full episode below.

Read more about our collaboration with argenx here: chaidiscovery.com/news/argen…

It’s been a landmark few days for Chai Discovery. From announcing our $400M Series C funding round and our collaboration with @Novartis, to working with argenx, the pace towards better drug design is faster than ever.

We’re delighted to announce our third agreement this week, this time a collaboration with @argenxglobal. argenx has built one of biotechnology’s most productive antibody engines. We’ll be putting Chai’s frontier molecular design platform into the hands of their scientists.

Read more from @m_delamerced in the @nytimes: nytimes.com/2026/07/14/busin…